Emission Monitoring Under EPA and CPCB for Pharma Sites Emission Monitoring Under EPA and CPCB for Pharma Sites In the pharmaceutical industry, compliance with environmental regulations is a critical component to ensure the safety of the public and the environment. This guide focuses on the key steps involved in emission monitoring under the Environmental Protection Agency (EPA) and the Central Pollution Control Board (CPCB) for pharma sites in the United States. It is geared towards professionals in Environmental, Health, and Safety (EHS), Regulatory Affairs, Quality Assurance, Supply Chain, and Sustainability/ESG sectors. This tutorial offers a structured approach while addressing practical…

Documentation for Waste and Emissions in CTD Module 3 Documentation for Waste and Emissions in CTD Module 3 In the pharmaceutical industry, ensuring compliance with environmental regulations is pivotal. This guide outlines a step-by-step process for documenting waste and emissions in the Common Technical Document (CTD) Module 3 in accordance with US Environmental Protection Agency (EPA) regulations, focusing on enterprise-level commitments for sustainability and compliance. Through this tutorial, professionals will gain insights into EPA compliance consulting strategies, from understanding regulatory requirements to implementing effective documentation practices. Step 1: Understanding Regulatory Frameworks and Requirements The first step in ensuring proper documentation…

Incineration vs Biodegradation: Regulatory Viewpoints on Waste Handling Incineration vs Biodegradation: Regulatory Viewpoints on Waste Handling Waste management is a critical aspect of environmental sustainability in the pharmaceutical and healthcare industries. As regulators increasingly emphasize the need for sustainable waste disposal methods, understanding the regulatory frameworks surrounding incineration and biodegradation becomes paramount. This article aims to provide a comprehensive tutorial on the regulatory viewpoints for waste handling in the United States, focusing particularly on incineration and biodegradation. Each section outlines practical actions, documentation requirements, and compliance checklists that professionals in environmental health and safety (EHS), regulatory affairs, quality assurance (QA),…

SOPs and Training for Waste Segregation in Pharma SOPs and Training for Waste Segregation in Pharma Effective waste management in the pharmaceutical industry is critical not only for compliance with environmental regulations but also for promoting sustainability and protecting public health. The U.S. Environmental Protection Agency (EPA) and state agencies enforce strict regulations surrounding waste segregation, which requires pharmaceutical companies to implement robust Standard Operating Procedures (SOPs) and comprehensive training programs. This article provides a detailed step-by-step tutorial guide to developing SOPs and training for effective waste segregation, ensuring compliance with regulatory standards such as the Resource Conservation and Recovery…

Carbon Footprint Disclosures and Their Role in Regulatory Filings Carbon Footprint Disclosures and Their Role in Regulatory Filings In today’s regulatory landscape, organizations are increasingly held accountable for their environmental impacts, especially regarding their carbon footprint. This comprehensive guide aims to provide a step-by-step approach for Environmental Health and Safety (EHS) professionals, ensuring compliance with U.S. regulations concerning carbon footprint disclosures in regulatory filings. The tutorial encapsulates essential components of EHS compliance consulting and focuses on practical actions and necessary documentation. Step 1: Understand the Regulatory Framework for Carbon Footprint Disclosures Before embarking on carbon footprint disclosures, it is vital…

Public Health Risks from Improper Drug Disposal: Regulatory Response Public Health Risks from Improper Drug Disposal: Regulatory Response Step 1: Understanding the Regulatory Framework To address public health risks from improper drug disposal, it’s essential to first comprehend the legal and regulatory frameworks governing pharmaceutical wastes in the United States. The primary regulations include the Resource Conservation and Recovery Act (RCRA) administered by the Environmental Protection Agency (EPA), which controls hazardous waste management, and state-specific regulations that may further elaborate on or enforce this foundational framework. Within the RCRA, substances are classified into hazardous and non-hazardous wastes; pharmaceuticals often fall…

Linking Waste and Emissions to ESG Scorecards in Regulatory Reviews Linking Waste and Emissions to ESG Scorecards in Regulatory Reviews Environmental, Social, and Governance (ESG) factors have increasingly become a critical component in the assessment and oversight of pharmaceutical companies. Regulatory reviews are now placing higher scrutiny on waste management and emissions as part of the overall ESG assessment. This guide aims to provide a structured approach to linking waste and emissions reporting with ESG scorecards during regulatory reviews, with a focus on practical actions and documentation expectations as per the FDA, EPA, and other regulatory guidelines. Step 1: Understand…

EPA Compliance Consulting for Pharma Facilities in 2023: Air Permits, Wastewater, and Reporting EPA Compliance Consulting for Pharma Facilities in 2023: Air Permits, Wastewater, and Reporting As regulatory environments become increasingly stringent, pharmaceutical facilities must prioritize environmental compliance to meet the expectations set forth by the EPA. This article serves as a comprehensive, step-by-step guide for pharmaceutical professionals engaged in EPA compliance consulting, focusing on air permits, wastewater management, and reporting requirements. Step 1: Understanding EPA Regulations and Compliance Framework Before initiating any compliance activities, it is crucial for pharmaceutical professionals to understand the regulatory environment governed by the U.S….

Wastewater API Residue Risk Management: US Best Practices and Regulator Expectations in 2023 Wastewater API Residue Risk Management: US Best Practices and Regulator Expectations in 2023 Effective wastewater management of active pharmaceutical ingredients (APIs) is integral for ensuring both regulatory compliance and environmental sustainability. The U.S. Environmental Protection Agency (EPA) rigorously oversees wastewater treatment to control the release of hazardous substances, including volatile organic compounds (VOCs). Understanding the regulatory framework, including the Resource Conservation and Recovery Act (RCRA), and aligning with best practices for monitoring and mitigating environmental impact is paramount for pharmaceutical companies. In this in-depth guide, we will…

RCRA Hazardous Waste Classification for Pharma: US Compliance Checklist for 2023 RCRA Hazardous Waste Classification for Pharma: US Compliance Checklist for 2023 The Resource Conservation and Recovery Act (RCRA) facilitates the management and disposal of hazardous waste in the United States. For pharmaceutical entities, understanding the classification of hazardous waste under RCRA is not only a compliance necessity but also an essential aspect of environmental sustainability. This step-by-step tutorial encapsulates the various phases involved in ensuring compliance with RCRA hazardous waste regulations in the pharmaceutical industry. This guide places a significant emphasis on practical actions and documentation expectations aligned with…